A Model‐Based Approach to Evaluate Anti‐Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T‐Cell Bispecific Cibisatamab by Javier Sanchez, Philippe B. Pierrillas, Nicolas Frey, Gregor P. Lotz, Siv Jönsson, Lena E. Friberg, Nicolas Frances

Get full text

Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals by Sophie Tourdot, Daniel Baltrunkonis, Sofie Denies, Viswanath Devanarayan, Joanna Grudzinska-Goebel, Arno Kromminga, Gregor P. Lotz, Laurent Malherbe, Lydia Michaut, Karin N. Weldingh, Joao A. Pedras-Vasconcelos, Laura. I. Salazar-Fontana, Sebastian Spindeldreher, Zuben Sauna, Veerle Snoeck, Daniela Verthelyi, Daniel Kramer

Get full text

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform by Joanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, Kyra J. Cowan, Boris Gorovits, Maria Jadhav, Melody Janssen, Vibha Jawa, Andrea Kiessling, Daniel Kramer, Arno Kromminga, Arno Kromminga, Marcel van der Linden, Susana Liu, Gregor P. Lotz, Linlin Luo, Mantas Malisauskas, Céline Marban-Doran, Daniel T. Mytych, Elisa Oquendo Cifuentes, Susanne Pippig, Sandra Ribes, Myrthe Rouwette, Weiping Shao, Sophie Tourdot, Karin Nana Weldingh, Veerle Snoeck

Get full text